Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
29 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsAlligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013
(WorldNews Sweden)

 
 

23 march 2017 09:15:43

 
Alligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013
(WorldNews Sweden)
 


Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that the first phase I study with ADC-1013, a human, monospecific, agonistic IgG1 antibody for cancer immunotherapy, has been completed. Alligator will host a live webcast for analysts, investors and media today, 23th March 2017, at 10.30 CET. The phase I trial, which began in April 2015, is a dose-escalation study involving intratumoral and intravenous administration of ADC-1013 at five clinical sites in Sweden, Denmark and the UK (ClinicalTrials.gov: NCT02379741). The study is sponsored by Alligator and includes 24 patients and ten different tumor types. The data will now be analyzed, focusing on safety and...


 
4 viewsCategory: General > Europe > Sweden
 
Capio´s Nomination Committee proposes Board members for the Annual General Meeting 2017
(WorldNews Sweden)
Notice of Annual General Meeting of Mr Green & Co AB (publ)
(WorldNews Sweden)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten